Skip to content
logo_echo
  • Features
  • FAQs
  • Clinicians
  • Research
  • About Us
  • Contact Us
  • Investors
Menu
  • Features
  • FAQs
  • Clinicians
  • Research
  • About Us
  • Contact Us
  • Investors
Support
Login
logo_echo
  • Features
  • Clinicians
  • FAQs
  • Research
  • Investor Centre
  • About Us
  • Contact Us
  • Login
Menu
  • Features
  • Clinicians
  • FAQs
  • Research
  • Investor Centre
  • About Us
  • Contact Us
  • Login

News

  • Aug 07, 2023
  • News Resources

Enhanced detection of severe aortic stenosis via artificial intelligence: a clinical cohort study

Decision-support algorithm accurately identifies the phenotype associated with severe aortic stenosis, in addition to clinical

  • Jul 25, 2023
  • News

MST Access commences coverage of Echo IQ

  • Jul 24, 2023
  • News Study

Echo IQ on Channel 9: How AI is Helping with Life Threatening Heart Diagnoses

  • Jul 24, 2023
  • News

AI potentially detects 72% more heart disease patients

  • Jul 24, 2023
  • News

Hydrix to sell AI technology that improves identification of structural heart disease

  • Jul 24, 2023
  • News

Echo IQ’s AI Aims Straight for the Heart

logo_echo
#aiwithheart
Linkedin Twitter Youtube

EchoSolv™

  • Features
  • Pricing
  • FAQs
  • Research

Support

  • Login
  • Support Centre
  • API Docs

Company

  • About
  • News
  • Investor Centre
  • Contact Us

Legal

  • Policies
  • Privacy Policy
  • Security

ECHO IQ LIMITED

Address: Suite 404, 309 George Street, Sydney NSW 2000, Australia. Phone: +61 (0) 2 9159 3719. ABN 48 142 901 353.

© Copyright 2023 Echo IQ Limited. All rights reserved.